Article
Artemisinin Attenuates Transplant Rejection by Inhibiting Multiple Lymphocytes and Prolongs Cardiac Allograft Survival.
Frontiers in immunology - 1 Jan 2021
Yang Zhe, Han Fei, Liao Tao, Zheng Haofeng, Luo Zihuan, Ma Maolin, He Jiannan, Li Lei, Ye Yongrong, Zhang Rui, Huang Zhengyu, Zhang Yannan, Sun Qiquan
Abstract excerpt
Immunological rejection is an important factor resulting in allograft dysfunction, and more valid therapeutic methods need to be explored to improve allograft outcomes. Many researches have indicated that artemisinin and its derivative exhibits immunosuppressive functions, apart from serving as a traditional anti-malarial drug. In this assay, we further explored the therapeutic effects of artemisinin for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.